| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Michael Parker | Q29643394 |
| Ruth Horn | Q89722419 | ||
| P2093 | author name string | Ruth Horn | |
| P2860 | cites work | Procreative beneficence: why we should select the best children | Q28203845 |
| Letting the genome out of the bottle--will we get our wish? | Q28264215 | ||
| Ethical issues in consumer genome sequencing: Use of consumers' samples and data | Q28602462 | ||
| ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing | Q29616235 | ||
| Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data | Q30881351 | ||
| Prenatal whole genome sequencing: just because we can, should we? | Q33959897 | ||
| Return of genomic results to research participants: the floor, the ceiling, and the choices in between | Q34000877 | ||
| An exploration of genetic counselors' needs and experiences with prenatal chromosomal microarray testing | Q34099702 | ||
| Prenatal whole-genome sequencing--is the quest to know a fetus's future ethical? | Q34398040 | ||
| Promises, pitfalls and practicalities of prenatal whole exome sequencing | Q34558273 | ||
| Prenatal exome sequencing for fetuses with structural abnormalities: the next step | Q87662199 | ||
| Evolving applications of microarray analysis in prenatal diagnosis | Q35255522 | ||
| Public perspectives on returning genetics and genomics research results | Q35564757 | ||
| Pregnancy Loss Following Amniocentesis or CVS Sampling-Time for a Reassessment of Risk | Q35667154 | ||
| Genetic information: a joint account? | Q35838575 | ||
| Noninvasive whole-genome sequencing of a human fetus. | Q36048523 | ||
| Parents' perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders | Q36068717 | ||
| One-time general consent for research on biological samples | Q36412166 | ||
| An old problem in a new age: Revisiting the clinical dilemma of misattributed paternity | Q36699756 | ||
| The best possible child | Q37004931 | ||
| Non-invasive prenatal testing for single gene disorders: exploring the ethics | Q37044362 | ||
| Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units | Q37067727 | ||
| Criteria for fairly allocating scarce health-care resources to genetic tests: which matter most? | Q37397621 | ||
| Genome sequencing: a systematic review of health economic evidence | Q37418013 | ||
| Women's experiences receiving abnormal prenatal chromosomal microarray testing results | Q37424832 | ||
| Stakeholder views on returning research results | Q38164857 | ||
| Ethical issues raised by whole genome sequencing | Q38210301 | ||
| Managing the ethical challenges of next-generation sequencing in genomic medicine | Q38239811 | ||
| Prevalence and architecture of de novo mutations in developmental disorders | Q38991782 | ||
| The foundation of the child's right to an open future | Q39064683 | ||
| The new genetics and informed consent: differentiating choice to preserve autonomy | Q39411069 | ||
| Prenatal whole-exome sequencing: parental attitudes | Q40761599 | ||
| An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons | Q42091906 | ||
| Cell-free fetal DNA: the new tool in fetal medicine | Q42393162 | ||
| Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues | Q45183763 | ||
| The routine and the traumatic in prenatal genetic diagnosis: does clinical information inform patient decision-making? | Q47291099 | ||
| Imposing genetic diversity | Q48037197 | ||
| Advances in prenatal screening: the ethical dimension. | Q48609420 | ||
| An offer you can't refuse? Ethical implications of non-invasive prenatal diagnosis | Q49161578 | ||
| Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results. | Q51498901 | ||
| The search for clarity in communicating research results to study participants. | Q53132496 | ||
| Content Analysis of Informed Consent for Whole Genome Sequencing Offered by Direct-to-Consumer Genetic Testing Companies. | Q54465016 | ||
| Generic Consent for Genetic Screening | Q56894329 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Return of results: not that complicated? | Q57644037 | ||
| Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time | Q57785176 | ||
| Microarrays as a diagnostic tool in prenatal screening strategies: ethical reflection | Q58663048 | ||
| Revealing false paternity: some ethical considerations | Q58669807 | ||
| The disability rights critique of prenatal genetic testing. Reflections and Recommendations | Q73249140 | ||
| Disability equality and prenatal testing: contradictory or compatible? | Q79924672 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P433 | issue | 1 | |
| P921 | main subject | research ethics | Q1132684 |
| whole genome sequencing | Q2068526 | ||
| exome sequencing | Q5420592 | ||
| Maternal Serum Screening Test | Q73040089 | ||
| P304 | page(s) | 20-25 | |
| P577 | publication date | 2017-08-07 | |
| 2018-01-01 | |||
| P1433 | published in | Prenatal Diagnosis | Q15760059 |
| P1476 | title | Opening Pandora's box?: ethical issues in prenatal whole genome and exome sequencing | |
| P478 | volume | 38 |
| Q48280857 | Amniocentesis is still the best option for advanced genomic testing in case of fetal malformations |
| Q92475712 | Case report: targeted whole exome sequencing enables the first prenatal diagnosis of the lethal skeletal dysplasia Osteocraniostenosis |
| Q56517284 | Ethical and Counseling Challenges in Prenatal Exome Sequencing |
| Q92659362 | From diagnostic yield to clinical impact: a pilot study on the implementation of prenatal exome sequencing in routine care |
| Q89303078 | Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians |
| Q57643473 | Health professionals' and researchers' perspectives on prenatal whole genome and exome sequencing: 'We can't shut the door now, the genie's out, we need to refine it' |
| Q49339134 | Paediatric genomics: diagnosing rare disease in children |
| Q64108553 | Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study |
| Q34558273 | Promises, pitfalls and practicalities of prenatal whole exome sequencing |
| Q88212766 | Rapid prenatal diagnosis using targeted exome sequencing: a cohort study to assess feasibility and potential impact on prenatal counseling and pregnancy management |
| Q50083885 | Whole Exome Sequencing: Applications in Prenatal Genetics |
Search more.